They're in Switzerland and Germany.
Two more manufacturing sites have been approved by European health regulators for the BioNtech/Pfizer Covid vaccine.
The sites in Germany and Switzerland are expected to support the continued supply of the vaccine in the European Union.
According to the EMA, the sites can become operational immediately.
EMA has approved additional manufacturing sites for the production of Comirnaty, the #COVID19vaccine developed by BioNTech and Pfizer. https://t.co/kFXSVB6rRn#VaccinesWork #CovidVaccines pic.twitter.com/sKSBaBkrzu
— EU Medicines Agency (@EMA_News) June 22, 2021
G7 Meeting To Discuss EU Diesel Shortages
Nine Gaming Companies Under Investigation By CCPC
Taoiseach Highly Critical Of Israel In UN Address
Concerns After AI Agent Hacks Australian Gov. Website
Taoiseach And Ministers To Travel To New York For UN General Assembly
Google Fined €403M Over Handling Of Location Data
